Phellodendronoside A Exerts Anticancer Effects Depending on Inducing Apoptosis Through ROS/Nrf2/Notch Pathway and Modulating Metabolite Profiles in Hepatocellular Carcinoma

References

• Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol. 2009;44:96–101. doi:10.1007/s00535-008-2258-6
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods, and major patterns in globocan 2012. Int J Cancer. 2015;136:E359–86. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Giannelli G, Koudelkova P, Dituri F, et al. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65:798–808. doi:10.1016/j.jhep.2016.05.007
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Zhu HY, Luo H, Zhang WW, et al. Molecular mechanisms of cisplatin resistance in cervical cancer. Drug Des Devel Ther. 2016;10:1885–1895. doi:10.2147/DDDT.S106412
   PubMed Web of Science ®Google Scholar
• Meng FC, Wu ZF, Yin ZQ, et al. Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity. Chinese Med. 2018;13:13. doi:10.1186/s13020-018-0171-3
   PubMed Web of Science ®Google Scholar
• Chakraborty B, Mukerjee N, Maitra S, et al. Therapeutic potential of different natural products for the treatment of Alzheimer’s Disease. Oxid Med Cell Longev. 2022;22:6873874.
   Google Scholar
• Si Y, Wei W, Chen X, et al. A comprehensive study on the relieving effect of Lilium brownii on the intestinal flora and metabolic disorder in p-chlorphenylalanine induced insomnia rats. Pharm Biol. 2022;60:131–143. doi:10.1080/13880209.2021.2019283
   PubMed Web of Science ®Google Scholar
• Si Y, Li X, Guo T, et al. Isolation and characterization of phellodendronoside A, a new isoquinoline alkaloid glycoside with anti-inflammatory activity from Phellodendron chinense Schneid. Fitoterapia. 2021;154:105021. doi:10.1016/j.fitote.2021.105021
   PubMed Web of Science ®Google Scholar
• Chen ML, Xian YF, Ip SP, et al. Chemical and biological differentiation of cortex Phellodendri chinensis and cortex Phellodendri amurensis. Planta Med. 2010;76:1530–1535. doi:10.1055/s-0030-1249774
   PubMed Web of Science ®Google Scholar
• Liu D, Meng X, Wu D, et al. A natural isoquinoline alkaloid with antitumor activity: studies of the biological activities of berberine. Front Pharmacol. 2019;10:9. doi:10.3389/fphar.2019.00009
   PubMed Web of Science ®Google Scholar
• Xu Z, Feng W, Shen Q, et al. Rhizoma coptidis and berberine as a natural drug to combat aging and aging-related diseases via anti-oxidation and AMPK activation. Aging Dis. 2017;8:760–777. doi:10.14336/AD.2016.0620
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629–661. doi:10.1021/acs.jnatprod.5b01055
   PubMed Web of Science ®Google Scholar
• Shang XF, Yang CJ, Morris-Natschke SL, et al. Biologically active isoquinoline alkaloids covering 2014–2018. Med Res Rev. 2020;40:2212–2289. doi:10.1002/med.21703
   PubMed Web of Science ®Google Scholar
• He D, Ma Z, Xue K, et al. Juxtamembrane 2 mimic peptide competitively inhibits mitochondrial trafficking and activates ROS-mediated apoptosis pathway to exert anti-tumor effects. Cell Death Dis. 2022;13:264. doi:10.1038/s41419-022-04639-6
   PubMed Web of Science ®Google Scholar
• Adjei AA. Blocking oncogenic Ras signaling for cancer therapy. Jnci J Natl Cancer I. 2001;93:1062–1074. doi:10.1093/jnci/93.14.1062
   Web of Science ®Google Scholar
• Chen S, Cheng AC, Wang MS, et al. Detection of apoptosis induced by new type gosling viral enteritis virus in vitro through fluorescein Annexin V-FITC/PI double labeling. World J Gastroenterol. 2008;14:2174–2178. doi:10.3748/wjg.14.2174
   PubMed Web of Science ®Google Scholar
• O’Connor MJ, Thakar T, Nicolae CM, et al. PARP14 regulates cyclin D1 expression to promote cell-cycle progression. Oncogene. 2021;40:4872–4883. doi:10.1038/s41388-021-01881-8
   PubMed Web of Science ®Google Scholar
• Welcker M, Clurman B. Cell cycle: how cyclin E got its groove back. Curr Biol. 2005;5:R810–2. doi:10.1016/j.cub.2005.09.018
   Google Scholar
• Narasimha AM, Kaulich M, Shapiro GS, et al. Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. Elife. 2014;2014:3.
   Google Scholar
• Qi R, An H, Yu Y, et al. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res. 2003;63:8323–8329.
   PubMed Web of Science ®Google Scholar
• Geisler F, Strazzabosco M. Emerging roles of Notch signaling in liver disease. Hepatology. 2015;61:382–392. doi:10.1002/hep.27268
   PubMed Web of Science ®Google Scholar
• Zong Y, Panikkar A, Xu J, et al. Notch signaling controls liver development by regulating biliary differentiation. Development. 2009;136:1727–1739. doi:10.1242/dev.029140
   PubMed Web of Science ®Google Scholar
• Sajadimajd S, Khazaei M. Oxidative stress and cancer: the role of Nrf2. Curr Cancer Drug Targets. 2018;18:538–557. doi:10.2174/1568009617666171002144228
   PubMed Web of Science ®Google Scholar
• Zhang D, Hou Z, Aldrich KE, et al. A novel Nrf2 pathway inhibitor sensitizes keap1-mutant lung cancer cells to chemotherapy. Mol Cancer Ther. 2021;20:1692–1701. doi:10.1158/1535-7163.MCT-21-0210
   PubMed Web of Science ®Google Scholar
• Zhao Q, Mao A, Yan J, et al. Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells. Int J Oncol. 2016;48:765–773. doi:10.3892/ijo.2015.3301
   PubMed Web of Science ®Google Scholar
• de Oliveira MR, Brasil FB, Andrade CMB. Naringenin attenuates H2O2-induced mitochondrial dysfunction by an Nrf2-dependent mechanism in SH-SY5Y cells. Neurochem Res. 2017;42:3341–3350. doi:10.1007/s11064-017-2376-8
   PubMed Web of Science ®Google Scholar
• Xue DF, Zhou XM, Qiu JX. Emerging role of NRF2 in ROS-mediated tumor chemoresistance. Biomed Pharmacother. 2020;131:110676. doi:10.1016/j.biopha.2020.110676
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach. Nat Rev Drug Discov. 2009;8:579–591. doi:10.1038/nrd2803
   PubMed Web of Science ®Google Scholar
• Castaldo SA, Freitas JR, Conchinha NV, et al. The tumorigenic roles of the cellular REDOX regulatory systems. Oxid Med Cell Longev. 2016;2016:8413032. doi:10.1155/2016/8413032
   PubMed Web of Science ®Google Scholar
• Sosa V, Moline T, Somoza R, et al. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12:376–390. doi:10.1016/j.arr.2012.10.004
   PubMed Web of Science ®Google Scholar
• Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Bio. 2018;80:50–64.
   PubMed Web of Science ®Google Scholar
• Dong YJ, Gao WJ. The role of bcl-2, bax, and caspase-3 in apoptosis and its relationship. Chin J Gerontol. 2012;32:4828–4830.
   Google Scholar
• Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12:685–698. doi:10.1038/nrc3365
   PubMed Web of Science ®Google Scholar
• Mallilankaraman K, Cardenas C, Doonan PJ, et al. MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism. Nat Cell Biol. 2012;14:1336–1343. doi:10.1038/ncb2622
   PubMed Web of Science ®Google Scholar
• Tan KO, Fu NY, Sukumaran SK, et al. MAP-1 is a mitochondrial effector of Bax. Proc Natl Acad Sci USA. 2005;102:14623–14628. doi:10.1073/pnas.0503524102
   PubMed Web of Science ®Google Scholar
• Jin M, Wang J, Ji X, et al. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38:136. doi:10.1186/s13046-019-1135-x
   PubMed Web of Science ®Google Scholar
• Pope ED, Kimbrough EO, Vemireddy LP, et al. Aberrant lipid metabolism as a therapeutic target in liver cancer. Expert Opin Ther Targets. 2019;23:473–483. doi:10.1080/14728222.2019.1615883
   PubMed Web of Science ®Google Scholar
• Qu Q, Zeng F, Liu X, et al. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis. 2016;7:e2226. doi:10.1038/cddis.2016.132
   PubMed Web of Science ®Google Scholar
• Tarasenko TN, Cusmano-Ozog K, McGuire PJ. Tissue acylcarnitine status in a mouse model of mitochondrial beta-oxidation deficiency during metabolic decompensation due to influenza virus infection. Mol Genet Metab. 2018;125:144–152. doi:10.1016/j.ymgme.2018.06.012
   PubMed Web of Science ®Google Scholar
• Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2012;7:68. doi:10.1186/1750-1172-7-68
   PubMed Web of Science ®Google Scholar
• Yaligar J, Teoh WW, Othman R, et al. Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection. Sci Rep. 2016;6:20299. doi:10.1038/srep20299
   PubMed Web of Science ®Google Scholar
• Amanuma M, Nagai H, Igarashi Y. Sorafenib might induce sarcopenia in patients with hepatocellular carcinoma by inhibiting carnitine absorption. Anticancer Res. 2020;40:4173–4182. doi:10.21873/anticanres.14417
   PubMed Web of Science ®Google Scholar
• Denton R. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim Biophys Acta. 2009;1787:1309–1316. doi:10.1016/j.bbabio.2009.01.005
   PubMed Web of Science ®Google Scholar
• Zhang L, Qi J, Zhang X, et al. The regulatory roles of mitochondrial calcium and the mitochondrial calcium uniporter in tumor cells. Int J Mol Sci. 2022;23:6667. doi:10.3390/ijms23126667
   PubMed Web of Science ®Google Scholar
• Zhou Y, Jing S, Liu S, et al. Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy. J Nanobiotechnology. 2022;20:188. doi:10.1186/s12951-022-01392-y
   PubMed Web of Science ®Google Scholar
• Madduma Hewage S, Au-Yeung KKW, Prashar S, et al. Lingonberry improves hepatic lipid metabolism by targeting Notch1 signaling. Antioxidants. 2022;11:472. doi:10.3390/antiox11030472
   Web of Science ®Google Scholar
• Zhao NJ, Liao MJ, Wu JJ, et al. Curcumin suppresses Notch‑1 signaling: improvements in fatty liver and insulin resistance in rats. Mol Med Rep. 2018;17:819–826. doi:10.3892/mmr.2017.7980
   PubMed Web of Science ®Google Scholar
• Gao L, Lv G, Li R, et al. Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK/mTOR dependent autophagy activation. Cancer Lett. 2019;454:215–223. doi:10.1016/j.canlet.2019.04.009
   PubMed Web of Science ®Google Scholar
• Xie G, Wang X, Huang F, et al. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. Int J Cancer. 2016;139:1764–1775. doi:10.1002/ijc.30219
   PubMed Web of Science ®Google Scholar
• Allen K, Jaeschke H, Copple BL. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol. 2011;178:175–186. doi:10.1016/j.ajpath.2010.11.026
   PubMed Web of Science ®Google Scholar
• Beuers U, Bilzer M, Chittattu A, et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology. 2001;33:1206–1216. doi:10.1053/jhep.2001.24034
   PubMed Web of Science ®Google Scholar
• Chiang J, Ferrell JM. Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr. 2019;39:175–200.
   PubMed Web of Science ®Google Scholar
• Nomoto M, Miyata M, Yin S, et al. Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor. Biol Pharm Bull. 2009;32:172–178.
   PubMed Web of Science ®Google Scholar